Distinctive genotypes in infants with T‐cell acute lymphoblastic leukaemia
Open Access
- 24 July 2015
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 171 (4) , 574-584
Abstract
Summary: Infant T‐cell acute lymphoblastic leukaemia (iT‐ALL) is a very rare and poorly defined entity with a poor prognosis. We assembled a unique series of 13 infants with T‐ALL, which allowed us to identify genotypic abnormalities and to investigate prenatal origins. Matched samples (diagnosis/remission) were analysed by single nucleotide polymorphism‐array to identify genomic losses and gains. In three cases, we identified a recurrent somatic deletion on chromosome 3. These losses result in the complete deletion of MLF1 and have not previously been described in T‐ALL. We observed two cases with an 11p13 deletion (LMO2‐related), one of which also harboured a deletion of RB1. Another case presented a large 11q14·1‐11q23·2 deletion that included ATM and only five patients (38%) showed deletions of CDKN2A/B. Four cases showed NOTCH1 mutations; in one case FBXW7 was the sole mutation and three cases showed alterations in PTEN. KMT2A rearrangements (KMT2A‐r) were detected in three out of 13 cases. For three patients, mutations and copy number alterations (including deletion of PTEN) could be backtracked to birth using neonatal blood spot DNA, demonstrating an in utero origin. Overall, our data indicates that iT‐ALL has a diverse but distinctive profile of genotypic abnormalities when compared to T‐ALL in older children and adults.Keywords
Funding Information
- European Hematology Association
- Lady Tata Memorial Trust
- Inca
- CNPq
- FAPERJ
- Kay Kendall Leukaemia Fund
- Leukaemia & Lymphoma Research
- Institute of Cancer Research
This publication has 38 references indexed in Scilit:
- Developmental timing of mutations revealed by whole-genome sequencing of twins with acute lymphoblastic leukemiaProceedings of the National Academy of Sciences, 2013
- EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferationsLeukemia, 2012
- Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesisProceedings of the National Academy of Sciences, 2012
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemiaNature, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemiaBlood, 2009
- Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemiaThe Lancet Oncology, 2009
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic LeukemiaScience, 2008
- Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3The EMBO Journal, 2005
- Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic LeukemiaScience, 2004